Ali Silverstein, MPH
Ali Silverstein is a Research Scientist at Precision Health Economics. Her experience at PHE has focused largely on Markov models and claims data analysis, spanning a variety of therapeutic areas including hepatitis C, mental health and substance use, Alzheimer’s disease, and oncology. Prior to joining PHE, Ms. Silverstein worked with the Health and Wellness Department of Boston Public Schools to manage data and develop presentation materials for the results of health behavior surveys conducted throughout the district. She also has a breadth of experience in food and nutrition services education and programming in multiple school districts.
MPH, Tufts University
BA, American Studies and Community Health, Tufts University
- Sail K, et al. Lifetime costs of patients with chronic lymphocytic leukemia. Blood. 2017.
- Shafrin J, Lakdawalla DN, Macewan JP, Silverstein AR, Hatch A, Forma F. Adherence patterns among patients using oral atypical antipsychotics and other medications. Value in Health. 2017; 20(9): A403.
- Van Nuys K, Chou JW, Silverstein A, Brookmeyer R, Goldman DP. The impact of broader hepatitis C treatment strategies on population health and social value in England. Journal of Hepatology. 2017; 66(1 suppl.): S407.